Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs032180067Completed
Randomised, open-label trial of propofol, remifentanil and rocuronium (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Percentage of intraoperative time in appropriate anesthesia state (composite). Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs032180067.